Hasna Bashir Iwas v. United States

I. Is authorization under the Controlled Substances Act defined in terms of the regulatory definition of an effective prescription or by the plain meaning of the statutory text? II. Does the mens rea required under 21 U.S.C. § 841(a) and this Court’s opinion in Ruan attach to the fact of non-authorization or to the regulatory standard for an effective prescription contained in 21 C.F.R. § 1306.04? LIST OF PARTIES TO THE PROCEEDINGS Petitioner, defendant-appellant below, Hasna Bashir Iwas. Respondent is the United States of America, appellee below. RELATED PROCEEDINGS Ninth Circuit Court of Appeals: United States v. Iwas, No. 24-1234, 2025 WL 2955197, at *1 (6th Cir. Oct. 20, 2025) Mandate Issued December 11, 2025. United States District Court for the Eastern District of Michigan: United States v. Iwas, No 2:18-cr-20769LJM-RSW-5. Judgement and conviction entered March 19, 2024.